Search

Your search keyword '"Soares RD"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Soares RD" Remove constraint Author: "Soares RD"
43 results on '"Soares RD"'

Search Results

1. Photobiomodulation for the prevention and treatment of oral mucositis in patients submitted to hematopoietic stem cell transplantation: health quality evaluation.

2. CD4 + T-lymphocytes from asymptomatic dogs infected with Leishmania infantum are able to activate macrophages for higher leishmanicidal ability in an in vitro co-culture experiment.

3. Gestational and Neonatal Outcomes in Cities in the Largest Coal Mining Region in Brazil.

4. LBMPL Vaccine Therapy Induces Progressive Organization of the Spleen Microarchitecture, Improved Th1 Adaptative Immune Response and Control of Parasitism in Leishmania infantum Naturally Infected Dogs.

5. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.

6. Sesquiterpene lactones from Lychnophora species: Antinociceptive, anti-inflammatory, and antioxidant pathways to treat acute gout.

7. Establishment of monoclonal antibodies to evaluate the cellular immunity in a hamster model of L infantum infection.

8. Recent advances and new strategies on leishmaniasis treatment.

9. Impact of Treatment Prior to Allogeneic Transplantation of Hematopoietic Stem Cells in Patients with Myelodysplastic Syndrome: Results of the Latin American Bone Marrow Transplant Registry.

11. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.

12. Superficial Acral Fibromyxoma: Literature Review.

13. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.

14. The Schistosomiasis SpleenOME: Unveiling the Proteomic Landscape of Splenomegaly Using Label-Free Mass Spectrometry.

15. A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden.

16. Proprioceptive-Visual Integration and Embodied Cognition: A Developmental Perspective.

17. Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.

18. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.

19. Patients with HIV/Aids and ulcer risk: nursing care demands.

20. In Vitro Behavior of Osteoblasts on Zirconia After Different Intensities of Erbium, Chromium-Doped: Yttrium, Scandium, Gallium, and Garnet-Laser Irradiation.

21. Monitoring the evolution of volatile compounds using gas chromatography during the stages of production of Moscatel sparkling wine.

22. Setting the proportion of CD4+ and CD8+ T-cells co-cultured with canine macrophages infected with Leishmania chagasi.

23. Metabolic syndrome in children and adolescents with phenylketonuria.

24. The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs.

25. Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum.

26. Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.

27. Shotgun proteomics to unravel the complexity of the Leishmania infantum exoproteome and the relative abundance of its constituents.

28. Evaluation of change in canine diagnosis protocol adopted by the visceral leishmaniasis control program in Brazil and a new proposal for diagnosis.

29. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

30. Clinical forms of canine visceral Leishmaniasis in naturally Leishmania infantum-infected dogs and related myelogram and hemogram changes.

31. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis.

32. Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis.

33. Evaluation of a prototype flow cytometry test for serodiagnosis of canine visceral leishmaniasis.

34. Analysis using canine peripheral blood for establishing in vitro conditions for monocyte differentiation into macrophages for Leishmania chagasi infection and T-cell subset purification.

35. Canine visceral leishmaniasis: incidence and risk factors for infection in a cohort study in Brazil.

36. Selenium intake and nutritional status of children with phenylketonuria in Minas Gerais, Brazil.

37. Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT.

38. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.

39. Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods.

40. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.

41. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs.

42. Breastfeeding in the treatment of children with phenylketonuria.

43. Post-natal development modulates the rat seminal vesicle sensitivity to sympathomimetic agonists.

Catalog

Books, media, physical & digital resources